Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Orion Oyj    ORNBV   FI0009014377

ORION OYJ (ORNBV)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Helsinki Ltd.
02/19/2018 02/20/2018 02/21/2018 02/22/2018 02/23/2018 Date
27.42(c) 27.38(c) 27.27(c) 27.1(c) 26.89(c) Last
300 093 398 177 391 220 370 803 417 745 Volume
+0.29% -0.15% -0.40% -0.62% -0.77% Change
More quotes
Financials (€)
Sales 2018 1 064 M
EBIT 2018 284 M
Net income 2018 230 M
Finance 2018 19,6 M
Yield 2018 5,24%
Sales 2019 1 107 M
EBIT 2019 298 M
Net income 2019 246 M
Finance 2019 32,3 M
Yield 2019 5,46%
P/E ratio 2018 17,39
P/E ratio 2019 16,10
EV / Sales2018 3,71x
EV / Sales2019 3,55x
Capitalization 3 966 M
More Financials
Company
Orion Oyj engages in the development of pharmaceutical and diagnostic test.It develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests.Its pharmaceutical research and development focuses on central nervous system drugs,... 
Sector
Pharmaceuticals
Calendar
03/20 | 01:00pmShareholder meeting
More about the company
Surperformance© ratings of Orion Oyj
Trading Rating : Investor Rating :
More Ratings
Latest news on ORION OYJ
02/07European shares recover from seven-day losing streak
RE
02/07European shares recover from seven-day losing streak
RE
02/07ORION OYJ : Notice to the annual general meeting of Orion Corporation
GL
02/07ORION OYJ : Group Financial Statement Release for 2017
GL
02/02ORION OYJ : annual earnings release
01/24ORION OYJ : Recommendation by the Nomination Committee concerning Board of Direc..
GL
01/24ORION OYJ : Publishing of Orion Corporation's Financial Statement Release for 20..
GL
01/23ORION OYJ : to investigate possible sale of Diagnostica
GL
01/04ORION OYJ : to renew operating model of its laboratories
GL
01/03ORION CORPORATION : Managers' transactions - Ylppö Jukka
AQ
More news
Sector news : Pharmaceuticals - NEC
01:46pPUMA BIOTECHNOLOGY : EU panel recommends against nod for Puma Biotech's breast c..
RE
12:30pSANOFI : Says U.S. Waiting Period for Bioverativ Has Expired
DJ
11:10aSHIRE : FDA to Conduct Priority Review of Shire Genetic-Disorder Drug
DJ
08:48aNOVARTIS : Greek Parliament Approves Bribery and Price Fix Inquiry on Novartis -..
DJ
02/22NOVARTIS : Greek Parliament Investigates Politicians in Novartis Bribery Probe
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
05:28aOrion Engineered Carbons $OEC Releases Earnings Results, Misses Expectations .. 
01:53a$OEC: Orion Engineered Carbons beats on top/bottom lines with EBITDA near hig.. 
02/22Orion Engineered Carbons beats by €0.03, beats on revenue  
02/22Orion Engineered Carbons S.A. : Announces Fourth Quarter and Full Year 2017 F.. 
02/22#Space: #Orion molecular cloud complex and its fabulous #nebulae
31
More tweets
Qtime:151
News from SeekingAlpha
2017Orion Corporation (ORINF) Investor Presentation - Slideshow 
2017Orion Corporation (ORINF) Investor Presentation - Slideshow 
Chart ORION OYJ
Duration : Period :
Orion Oyj Technical Analysis Chart | ORNBV | FI0009014377 | 4-Traders
Technical analysis trends ORION OYJ
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 32,6 €
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Timo Antero Lappalainen President & Chief Executive Officer
Heikki Seppo Westerlund Chairman
Jari Karlson CFO, SVP-Animal Health & IR Contact
Christer Nordstedt Senior Vice President-Research & Development
Sirpa Tuulikki Jalkanen Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORION OYJ-12.81%4 879
JOHNSON & JOHNSON-7.02%349 006
NOVARTIS-2.94%224 221
PFIZER-1.27%213 155
ROCHE HOLDING LTD.-9.41%207 327
MERCK AND COMPANY-3.06%148 618